BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Enomoto H, Bando Y, Nakamura H, Nishiguchi S, Koga M. Liver fibrosis markers of nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(24): 7427-7435 [PMID: 26139988 DOI: 10.3748/wjg.v21.i24.7427]
URL: https://www.wjgnet.com/1007-9327/full/v21/i24/7427.htm
Number Citing Articles
1
Ahmed Ba‐Ssalamah, Nina Bastati, Andreas Wibmer, Romana Fragner, Jacqueline C. Hodge, Michael Trauner, Christian J. Herold, Mustafa R. Bashir, Bernard E. Van Beers. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?Journal of Magnetic Resonance Imaging 2017; 45(3): 646 doi: 10.1002/jmri.25518
2
Hsu-Feng Lu, Yu-Heng Lai, Hsiu-Chen Huang, I-Jung Lee, Lie-Chwen Lin, Hui-Kang Liu, Hsiao-Hsuan Tien, Cheng Huang. Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in miceJournal of Ginseng Research 2020; 44(2): 238 doi: 10.1016/j.jgr.2018.10.005
3
Luis Rolando Guarneros-Nolasco, Giner Alor-Hernández, Guillermo Prieto-Avalos, José Luis Sánchez-Cervantes. Early Identification of Risk Factors in Non-Alcoholic Fatty Liver Disease (NAFLD) Using Machine LearningMathematics 2023; 11(13): 3026 doi: 10.3390/math11133026
4
Evrim Kahramanoğlu Aksoy, Zeynep Göktaş, Özgür Albuz, Muhammet Yener Akpınar, Doğan Öztürk, Hakan Buluş, Metin Uzman. Effects of sleeve gastrectomy on liver enzymes, non-alcoholic fatty liver disease-related fibrosis and steatosis scores in morbidly obese patients: first year follow-upJournal of Laboratory Medicine 2019; 43(2): 115 doi: 10.1515/labmed-2018-0181
5
Katelynn S. Madill-Thomsen, Marwan Abouljoud, Chandra Bhati, Michał Ciszek, Magdalena Durlik, Sandy Feng, Bartosz Foroncewicz, Iman Francis, Michał Grąt, Krzysztof Jurczyk, Goran Klintmalm, Maciej Krasnodębski, Geoff McCaughan, Rosa Miquel, Aldo Montano-Loza, Dilip Moonka, Krzysztof Mucha, Marek Myślak, Leszek Pączek, Agnieszka Perkowska-Ptasińska, Grzegorz Piecha, Trevor Reichman, Alberto Sanchez-Fueyo, Olga Tronina, Marta Wawrzynowicz-Syczewska, Andrzej Więcek, Krzysztof Zieniewicz, Philip F. Halloran. The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER studyAmerican Journal of Transplantation 2022; 22(3): 909 doi: 10.1111/ajt.16890
6
Tong-Shuo Zhang, Hua-Lei Qin, Tong Wang, Hai-Tao Li, Hai Li, Shi-Hai Xia, Xiao-Hui Xiang. Bibliometric analysis of top 100 cited articles in nonalcoholic fatty liver disease researchWorld Journal of Hepatology 2016; 8(33): 1478-1488 doi: 10.4254/wjh.v8.i33.1478
7
Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 423 doi: 10.1007/978-3-030-11748-1_16
8
Pei-Xin Hu, Mei-Yan Sheng, Yan-Ping Liu, Chun-Qing Zhang. FOSL2 deficiency delays nonalcoholic steatohepatitis progression by regulating LY6D-mediated NLRP3 activationHuman Cell 2022; 35(6): 1752 doi: 10.1007/s13577-022-00760-y
9
Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Kyohei Kishino, Yoshihiro Shimono, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Kazunori Yoh, Takashi Nishimura, Nobuhiro Aizawa, Yoshiyuki Sakai, Naoto Ikeda, Tomoyuki Takashima, Akio Ishii, Hiroko Iijima, Hideji Nakamura, Shuhei Nishiguchi. Clinical significance of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein level in non‐alcoholic steatohepatitisHepatology Research 2016; 46(12): 1194 doi: 10.1111/hepr.12662
10
Mahmoud Aryan, Ravi Jariwala, Basem Alkurdi, Shajan Peter, Mohamed Shoreibah. Prevalence of metabolic syndrome in cirrhotics with gastric antral vascular ectasiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(1): 102377 doi: 10.1016/j.dsx.2021.102377
11
Devon Chang, Emily Truong, Edward A. Mena, Fabiana Pacheco, Micaela Wong, Maha Guindi, Tsuyoshi T. Todo, Nabil Noureddin, Walid Ayoub, Ju Dong Yang, Irene K. Kim, Anita Kohli, Naim Alkhouri, Stephen Harrison, Mazen Noureddin. Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD‐related cirrhosisHepatology 2023; 77(2): 546 doi: 10.1002/hep.32655
12
Zu-Yin Li, Gang Wu, Chen Qiu, Zhi-Jie Zhou, Yu-Peng Wang, Guo-He Song, Chao Xiao, Xin Zhang, Gui-Long Deng, Rui-Tao Wang, Yu-Long Yang, Xiao-Liang Wang. Mechanism and therapeutic strategy of hepatic <i>TM6SF2</i>-deficient non-alcoholic fatty liver diseases <i>via in vivo</i> and <i>in vitro</i> experimentsWorld Journal of Gastroenterology 2022; 28(25): 2937-2954 doi: 10.3748/wjg.v28.i25.2937
13
Adi S. Yehezkel, Nathalie Abudi, Yuval Nevo, Hadar Benyamini, Sharona Elgavish, Marta Weinstock, Rinat Abramovitch. AN1284 attenuates steatosis, lipogenesis, and fibrosis in mice with pre-existing non-alcoholic steatohepatitis and directly affects aryl hydrocarbon receptor in a hepatic cell lineFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1226808
14
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructoseBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
15
Qi Liu, Yue Sun, Yue Zhu, Senqiu Qiao, Jingzeng Cai, Ziwei Zhang. Melatonin relieves liver fibrosis induced by Txnrd3 knockdown and nickel exposure via IRE1/NF-kB/NLRP3 and PERK/TGF-β1 axis activationLife Sciences 2022; 301: 120622 doi: 10.1016/j.lfs.2022.120622
16
Huimin Dong, Lu Zhao, Hengchang Sun, Mei Shang, Gang Lv, Xinbing Yu, Bo Hu, Yan Huang. Coinfection of Clonorchis sinensis and hepatitis B virus: clinical liver indices and interaction in hepatic cell modelsParasites & Vectors 2022; 15(1) doi: 10.1186/s13071-022-05548-5
17
Yukimura Higashiura, Marenao Tanaka, Kazuma Mori, Takuma Mikami, Itaru Hosaka, Hirofumi Ohnishi, Nagisa Hanawa, Masato Furuhashi, Magnus Bäck. High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general populationEuropean Heart Journal Open 2022; 2(3) doi: 10.1093/ehjopen/oeac030
18
V A Akhmedov, O V Gaus. Involvement of the hepatobiliary system and pancreas in obesityTerapevticheskii arkhiv 2017; 89(1): 128 doi: 10.17116/terarkh2017891128-133
19
Jung Yoon Pyo, Sung Soo Ahn, Lucy Eunju Lee, Ha Na Choe, Jason Jungsik Song, Yong‐Beom Park, Sang‐Won Lee. Efficacy of the fibrosis index for predicting end‐stage renal disease in patients with antineutrophil cytoplasmic antibody‐associated vasculitisInternational Journal of Clinical Practice 2021; 75(4) doi: 10.1111/ijcp.13929
20
Narriane C. P. Holanda, Amanda R. L. Oliveira, Nara N. C. Carvalho, Bruno L. Souza. Endocrinology and Diabetes2022; : 443 doi: 10.1007/978-3-030-90684-9_42
21
Mandour Omer Mandour, Mohammed El-Hassan, Rawan M Elkomi, Jude A Oben. Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?World Journal of Hepatology 2022; 14(9): 1704-1717 doi: 10.4254/wjh.v14.i9.1704
22
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosisWorld Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
23
Ellen Vercalsteren, Christine Vranckx, Liesbeth Frederix, Marleen Lox, H. Roger Lijnen, Ilse Scroyen, Bianca Hemmeryckx. Advanced-age C57BL/6JRj mice do not develop obesity upon western-type diet exposureAdipocyte 2019; 8(1): 105 doi: 10.1080/21623945.2019.1590893
24
Fengxing Li, Kai Zou, Ning Chen. Exercise, Autophagy and Chronic Diseases2021; : 81 doi: 10.1007/978-981-16-4525-9_5
25
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
26
Shu‐Chen Cheng, Chian‐Jiun Liou, Ya‐Xuan Wu, Kuo‐Wei Yeh, Li‐Chen Chen, Wen‐Chung Huang. Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in miceThe Kaohsiung Journal of Medical Sciences 2024; 40(3): 280 doi: 10.1002/kjm2.12795
27
Rochelle W. Lai, Ryan Lu, Prakroothi S. Danthi, Juan I. Bravo, Alexandre Goumba, Nirmal Kumar Sampathkumar, Bérénice A. Benayoun. Multi-level remodeling of transcriptional landscapes in aging and longevityBMB Reports 2019; 52(1): 86 doi: 10.5483/BMBRep.2019.52.1.296
28
Chao Zhang, Chuanbao Zhang. Analysis of current status of quantitative detection of biomarkers for liver fibrosis in Clinical labs in ChinaJournal of Clinical Laboratory Analysis 2022; 36(7) doi: 10.1002/jcla.24490
29
Ting Zhai, Wei Xu, Yayun Liu, Kun Qian, Yanling Xiong, Yong Chen, Tullia Maraldi. Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK PathwayOxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/2313641
30
Yingwei Zhu, Hong Tang, Han Zhao, Jian Lu, Kai Lin, Jingbin Ni, Bo Zhao, Gaojue Wu, Chunxiao Tan. Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-κB signalingGastroenterología y Hepatología 2024; 47(4): 366 doi: 10.1016/j.gastrohep.2023.07.006
31
Yun Feng, Wenhua Li, Zhuoya Wang, Ruling Zhang, Yan Li, Lijuan Zang, Peiwen Wang, Zhenghong Li, Yuwei Dong. The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitisJournal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03692-1
32
Hua-Chien Wu, Yin-Ru Hsieh, Weu Wang, Ching-Wen Chang, I-Wei Chang, Chi-Long Chen, Chun-Chao Chang, Chia-Hsuan Chang, Wei-Yu Kao, Shih-Yi Huang. Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity PatientsJournal of Clinical Medicine 2023; 12(11): 3730 doi: 10.3390/jcm12113730
33
Sang Oh Yun, Jong Man Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh. Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populationsAnnals of Surgical Treatment and Research 2023; 104(4): 195 doi: 10.4174/astr.2023.104.4.195
34
Anushri Parakh, Vinit Baliyan, Dushyant V. Sahani. Dual-Energy CT in Focal and Diffuse Liver DiseaseCurrent Radiology Reports 2017; 5(8) doi: 10.1007/s40134-017-0226-8
35
You Yang, Xile Jiang, Stephen J. Pandol, Yuan-Ping Han, Xiaofeng Zheng. Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in MiceFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.739174
36
Julie F.N. Potier, Andy E. Durham, Raakesh Modi, William Rosenberg, Sophie A. Dash. Investigation of Serum Markers of Hepatic Fibrosis in EquidsJournal of Equine Veterinary Science 2023; 131: 104937 doi: 10.1016/j.jevs.2023.104937
37
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
38
Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver DiseasesBiomolecules 2024; 14(3): 277 doi: 10.3390/biom14030277
39
Letícia F Ramos, Caio M Silva, Camila C Pansa, Karen C M Moraes. Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liverExpert Review of Gastroenterology & Hepatology 2021; 15(1): 25 doi: 10.1080/17474124.2020.1820321
40
Xiangzhou Shi, Jinghua Li, Binying Min, Ruijing Yang, Chunxiang He, Yilin Yang, Chen Ling. Application of ultrasound elastography for monitoring the effects of TβR1 shRNA therapy on hepatic fibrosis in a rat modelPLOS ONE 2021; 16(6): e0253150 doi: 10.1371/journal.pone.0253150
41
O. S. Popova, V. S. Ponamarev, A. V. Kostrova, L. A. Agafonova. Use of modern methods for diagnostics of diseases of the heptobiliary systemInternational Journal of Veterinary Medicine 2023; (1): 113 doi: 10.52419/issn2072-2419.2023.1.113
42
Luai Huleihel, Michelle E. Scarritt, Stephen F. Badylak. The Influence of Extracellular RNA on Cell Behavior in Health, Disease, and RegenerationCurrent Pathobiology Reports 2017; 5(1): 13 doi: 10.1007/s40139-017-0121-2
43
Lina Jiang, Mei Yang, Xi Li, Yijin Wang, Guangde Zhou, Jingmin Zhao. CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte–Stellate Cell CrosstalkThe Journal of Clinical Endocrinology & Metabolism 2018; 103(11): 3974 doi: 10.1210/jc.2018-00762
44
Saleh A. Alqahtani, Pegah Golabi, James M. Paik, Brian Lam, Amir H. Moazez, Hazem A. Elariny, Zachary Goodman, Zobair M. Younossi. Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver DiseaseObesity Surgery 2021; 31(5): 2002 doi: 10.1007/s11695-020-04996-1
45
Daniel A. Montes-Galindo, Ana C. Espiritu-Mojarro, Valery Melnikov, Norma A. Moy-López, Alejandro D. Soriano-Hernandez, Hector R. Galvan-Salazar, Jorge Guzman-Muñiz, Jose Guzman-Esquivel, Margarita L. Martinez-Fierro, Iram P. Rodriguez-Sanchez, Brenda Paz-Michel, Sergio A. Zaizar-Fregoso, Carmen A. Sanchez-Ramirez, Mario Ramirez-Flores, Ivan Delgado-Enciso. Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamstersArchives of Virology 2019; 164(3): 775 doi: 10.1007/s00705-018-04132-6
46
Yi-Jie Mao, Miao-Miao Ying, Gang Xu. Identification of hub genes and small molecule therapeutic drugs related to simple steatosis with secondary analysis of existing microarray dataAll Life 2022; 15(1): 921 doi: 10.1080/26895293.2022.2114550
47
Madlen Matz-Soja, Christiane Rennert, Kristin Schönefeld, Susanne Aleithe, Jan Boettger, Wolfgang Schmidt-Heck, Thomas S Weiss, Amalya Hovhannisyan, Sebastian Zellmer, Nora Klöting, Angela Schulz, Jürgen Kratzsch, Reinhardt Guthke, Rolf Gebhardt. Hedgehog signaling is a potent regulator of liver lipid metabolism and reveals a GLI-code associated with steatosiseLife 2016; 5 doi: 10.7554/eLife.13308
48
Rieko Nakatani, Takashi Murata, Takeshi Usui, Koki Moriyoshi, Toshiki Komeda, Yuichi Masuda, Maiko Kakita-Kobayashi, Tetsuya Tagami, Shinsaku Imashuku, Shigeo Kono, Kazunori Yamada, Akira Shimatsu. Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver CirrhosisInternal Medicine 2018; 57(4): 537 doi: 10.2169/internalmedicine.9135-17
49
Nidhi Sharma, Ramakrishna Sistla, Sai Balaji Andugulapati. Yohimbine ameliorates liver inflammation and fibrosis by regulating oxidative stress and Wnt/β-catenin pathwayPhytomedicine 2024; 123: 155182 doi: 10.1016/j.phymed.2023.155182
50
Katarzyna Zdanowicz, Monika Kowalczuk-Kryston, Witold Olanski, Irena Werpachowska, Wlodzimierz Mielech, Dariusz Marek Lebensztejn. Increase in Serum MMP-9 and TIMP-1 Concentrations during Alcohol Intoxication in Adolescents—A Preliminary StudyBiomolecules 2022; 12(5): 710 doi: 10.3390/biom12050710
51
Iria Cebreiros López, José Antonio Noguera Velasco. Valoración de la enfermedad por hígado graso no alcohólico desde el laboratorio clínicoRevista del Laboratorio Clínico 2018; 11(3): 163 doi: 10.1016/j.labcli.2017.10.004